Epidermal growth factor receptor (EGFR) has been proved to be related with the pathogenesis and progression of multiple carcinoma types, including lung cancer [1], breast cancer [2], prostatic cancer [3] and pancreatic cancer [4]. This evidence concerns the gene EGFR and breast cancer.